Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Corcept Therapeutics Inc (CORT)  
$22.80 0.59 (2.66%) as of 4:30 Fri 4/26


Download
   
Exchange: Nasdaq Small Cap
Security Type: Common
Shares Out: 116,630,000
Market Cap: 2.66(B)
Last Volume: 820,436 Avg Vol: 990,000
52 Week Range: $21.1 - $33.8
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Corcept Therapeutics is a commercial-stage company engaged in the discovery and development of drugs that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effects of the hormone cortisol. Co. has marketed Korlym (mifepristone) in the U.S. for the treatment of patients with Cushing's syndrome. Co.'s primary compounds have entered the clinic as potential treatments for serious disorders, including Cushing's syndrome, solid tumors (such as ovarian cancer, castration-resistant prostate cancer and adrenocortical cancer with cortisol excess), antipsychotic induced weight gain and non-alcoholic steatohepatitis.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 88,543 140,536 318,791 928,421
Total Sell Value $2,237,891 $3,635,678 $8,712,718 $24,481,747
Total People Sold 3 5 7 8
Total Sell Transactions 10 18 37 55
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 487
  Page 10 of 20  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Baker G Leonard Jr Director   •       •      –    2020-11-17 4 B $17.82 $140,469 I/I 7,883 3,201,413 2.1 30%     
   Robb Gary Charles Chief Financial Officer   •       –      –    2020-11-16 4 GA $0.00 $0 I/I 2,487 4,564     -
   Baker G Leonard Jr Director   •       •      –    2020-11-13 4 B $17.94 $3,588 I/I 200 3,193,530 2.1 35%     
   Baker G Leonard Jr Director   •       •      –    2020-11-10 4 B $17.71 $265,635 I/I 15,000 3,193,330 2.1 37%     
   Baker G Leonard Jr Director   •       •      –    2020-11-09 4 B $17.96 $68,013 I/I 3,786 3,178,330 2.1 43%     
   Baker G Leonard Jr Director   •       •      –    2020-11-06 4 B $17.98 $242,665 I/I 13,500 3,174,544 2.1 42%     
   Swisher Daniel N Jr Director   –       •      –    2020-10-19 4 AS $17.66 $88,301 D/D (5,000) 0 44%     
   Swisher Daniel N Jr Director   –       •      –    2020-10-19 4 OE $6.55 $32,750 D/D 5,000 5,000     -
   Baker G Leonard Jr Director   •       •      –    2020-09-01 4 B $12.50 $322,526 I/I 25,807 3,161,044 2.1 115%     
   Baker G Leonard Jr Director   •       •      –    2020-08-28 4 B $12.48 $255,213 I/I 20,444 3,135,237 2.1 114%     
   Swisher Daniel N Jr Director   –       •      –    2020-07-17 4 AS $16.48 $82,411 D/D (5,000) 0 40%     
   Swisher Daniel N Jr Director   –       •      –    2020-07-17 4 OE $6.55 $32,750 D/D 5,000 5,000     -
   Hunt Hazel Chief Scientific OfficerOffice   •       –      –    2020-07-13 3 IO $0.00 $0 D/D 0 200 51%     
   Wilson James N Director   –       •      –    2020-07-10 4 GD $0.00 $0 I/I 12,500 1,319,074     -
   Baker G Leonard Jr Director   •       •      –    2020-05-28 4 S $15.70 $471,060 D/D (30,000) 996,838 -17%     
   Baker G Leonard Jr Director   •       •      –    2020-05-28 4 OE $3.47 $104,100 D/D 30,000 1,026,838     -
   Mahoney David L Director   –       •      –    2020-05-22 4 OE $3.47 $135,274 D/D 38,984 88,984     -
   Swisher Daniel N Jr Director   –       •      –    2020-05-22 4 AS $16.10 $80,500 D/D (5,000) 0 15%     
   Swisher Daniel N Jr Director   –       •      –    2020-05-22 4 OE $6.55 $32,750 D/D 5,000 5,000     -
   Belanoff Joseph K Chief Executive Officer   •       •      –    2020-02-26 4 D $13.54 $275,377 D/D (20,338) 2,499,214     -
   Robb Gary Charles Chief Financial Officer   •       –      –    2019-12-09 4 S $13.73 $412,029 D/D (30,000) 8,025     -
   Robb Gary Charles Chief Financial Officer   •       –      –    2019-12-09 4 OE $1.92 $57,600 D/D 30,000 38,025     -
   Wilson James N Director   –       •      –    2019-10-28 4/A D $14.63 $2,248,807 D/D (153,712) 246,288     -
   Wilson James N Director   –       •      –    2019-10-28 4 D $14.63 $2,249,421 D/D (153,754) 246,246     -
   Wilson James N Director   –       •      –    2019-10-28 4 OE $2.30 $653,701 D/D 284,218 400,000     -
  487 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 10 of 20
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us